ArticleBMC veterinary research2025
Deleting fis downregulates virulence and effectively protects Pasteurella multocida infection in mice.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Study on the Pathogenic Mechanism ofPathogens (Basel, Switzerland) · 2026Review
- Attenuation mechanisms and vaccine potential of the serial passage-derived Pasteurella multocida strain PMZ8 in ducks.Poultry science · 2026Article
- Design of a Multi-Epitope Vaccine Against OvineMicroorganisms · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Pasteurella multocida (P. multocida) is an important pathogen causing various diseases in both domestic and wild animals. The factor for inversion stimulation (Fis) is a nucleoid-associated protein with diverse functions in various bacteria, which positively regulate the transcription of capsular glycosaminoglycan genes in P. multocida. However, the precise mechanistic understanding of how the fis regulate virulence of P. multocida remains largely unknown. In this study, we discovered that fis transcript levels of P. multocida CQ2, serotype A (PmCQ2) were significantly increased in vivo, and showed a positive correlation with the capsule and virulence of P. multocida. To further understand how the fis regulated P. multocida pathogenesis, a homologous recombination strategy was used to generate fis-deleted strain. Then, the growth velocity, virulence characteristics, immune/inflammatory responses, and the survival rates of challenged mice were determined. The findings revealed that the presence of fis promoted the growth, regulated synthesis of capsule and biofilm of PmCQ2, and helped to resist phagocytosis by macrophages. Notably, we firstly demonstrated that Fis determined whether P. multocida can use bound iron ion for its survival. Consequently, the loss of fis greatly restricted P. multocida pathogenicity, as evidenced by reducing tissue bacterial loads as well as inflammatory factors levels. Moreover, the fis deletion strain was endowed with strong cross immunoprotected properties against P. multocida serotype A and B. Thus, these results suggested the pathogenic role of fis in P. multocida and proposed that fis deletion strain could be used as an attenuated vaccine candidate against P. multocida of serotype A and B.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.